Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centrafarm is a leading Dutch pharmaceutical company and a key subsidiary of the international STADA Group. Based in Etten-Leur, the company specializes in the development, marketing, and distribution of a wide range of generic medicines, biosimilars, and specialty pharmaceuticals. Centrafarm's extensive portfolio addresses numerous therapeutic areas, including oncology, cardiology, and central nervous system disorders, providing high-quality and affordable alternatives to off-patent brand-name drugs. The company plays a critical role in the Dutch healthcare system by collaborating closely with pharmacists, hospitals, and health insurers to ensure the availability of essential treatments. Leveraging STADA's global manufacturing and R&D infrastructure, Centrafarm maintains a strong market position through a focus on reliability and cost-efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centrafarm Nederland.